Cargando…

Weight Loss, Glycemic Control, and Changes in Cardiovascular Biomarkers in Patients With Type 2 Diabetes Receiving Incretin Therapies or Insulin in a Large Cohort Database

OBJECTIVE: Weight loss in patients with type 2 diabetes can improve glycemic control, lower blood pressure, and improve dyslipidemia. Glucagon-like peptide (GLP-1) receptor agonists are associated with weight loss and have potentially beneficial effects on cardiovascular risk biomarkers; however, th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Horton, Edward S., Silberman, Cheryl, Davis, Keith L., Berria, Rachele
Formato:	Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2010
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2909058/ https://www.ncbi.nlm.nih.gov/pubmed/20460445 http://dx.doi.org/10.2337/dc09-2062

Ejemplares similares

Achieving postprandial glucose control with lixisenatide improves glycemic control in patients with type 2 diabetes on basal insulin: a post-hoc analysis of pooled data
por: Davidson, Jaime A., et al.
Publicado: (2020)

Effects of meal composition on postprandial incretin, glucose and insulin responses after surgical and medical weight loss
por: Lee, C. J., et al.
Publicado: (2015)

Bone: Incretin Hormones Perceiver or Receiver?
por: Dicembrini, Ilaria, et al.
Publicado: (2012)

Incretin Hormones: The Link between Glycemic Index and Cardiometabolic Diseases
por: Salvatore, Teresa, et al.
Publicado: (2019)

Understanding the Cardiovascular Effects of Incretin
por: Yoon, Ji Sung, et al.
Publicado: (2011)

Incretin-Based Therapies: Focus on Effects Beyond Glycemic Control Alone
por: Davidson, Jaime A.
Publicado: (2013)

Treatment With the Human Once-Weekly Glucagon-Like Peptide-1 Analog Taspoglutide in Combination With Metformin Improves Glycemic Control and Lowers Body Weight in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Alone: A double-blind placebo-controlled study
por: Nauck, Michael A., et al.
Publicado: (2009)

Incretins in the ICU: is insulin on its way out?
por: Kovalaske, Michelle A, et al.
Publicado: (2009)

The Role of Incretins on Insulin Function and Glucose Homeostasis
por: Holst, Jens Juul, et al.
Publicado: (2021)

Predictive Modeling of Hypoglycemia Risk with Basal Insulin Use in Type 2 Diabetes: Use of Machine Learning in the LIGHTNING Study
por: Bosnyak, Zsolt, et al.
Publicado: (2019)

Insulin and incretin responses to grazing in insulin‐dysregulated and healthy ponies
por: Fitzgerald, Danielle M., et al.
Publicado: (2018)

Downregulation of CTRP-3 by Weight Loss In Vivo and by Bile Acids and Incretins in Adipocytes In Vitro
por: Schmid, Andreas, et al.
Publicado: (2020)

Glycemic, insulinemic and incretin responses after oral trehalose ingestion in healthy subjects
por: Yoshizane, Chiyo, et al.
Publicado: (2017)

How should we think about the unprecedented weight loss efficacy of incretin-mimetic drugs?
por: Gou, Yang, et al.
Publicado: (2023)

Optical Control of Insulin Secretion Using an Incretin Switch
por: Broichhagen, Johannes, et al.
Publicado: (2015)

Beyond Glycemic Control in Diabetes Mellitus: Effects of Incretin-Based Therapies on Bone Metabolism
por: Ceccarelli, Elena, et al.
Publicado: (2013)

The Change in Glucagon Following Meal Ingestion Is Associated with Glycemic Control, but Not with Incretin, in People with Diabetes
por: Yoo, Soyeon, et al.
Publicado: (2021)

Effects of Intraduodenal Glutamine on Incretin Hormone and Insulin Release, the Glycemic Response to an Intraduodenal Glucose Infusion, and Antropyloroduodenal Motility in Health and Type 2 Diabetes
por: Chang, Jessica, et al.
Publicado: (2013)

Weight Loss, Glycemic Control, and Cardiovascular Disease Risk Factors in Response to Differential Diet Composition in a Weight Loss Program in Type 2 Diabetes: A Randomized Controlled Trial
por: Rock, Cheryl L., et al.
Publicado: (2014)

The Influence of Incretin Mimetics on Cardiovascular Risk Factors in Diabetes
por: Kinalska, Ida, et al.
Publicado: (2012)

Incretins and cardiovascular disease: to the heart of type 2 diabetes?
por: Solini, Anna, et al.
Publicado: (2023)

Disparities in the Glycemic and Incretin Responses to Intraduodenal Glucose Infusion Between Healthy Young Men and Women
por: Xie, Cong, et al.
Publicado: (2023)

Relevance of the Glycemic Index and Glycemic Load for Body Weight, Diabetes, and Cardiovascular Disease
por: Vega-López, Sonia, et al.
Publicado: (2018)

Calorie Restriction and Matched Weight Loss From Exercise: Independent and Additive Effects on Glucoregulation and the Incretin System in Overweight Women and Men
por: Weiss, Edward P., et al.
Publicado: (2015)

Incretin Concepts
por: Bloomgarden, Zachary T.
Publicado: (2010)

Inflammation and incretins
por: Hatwal, Amitabh
Publicado: (2012)

Linagliptin Increases Incretin Levels, Lowers Glucagon, and Improves Glycemic Control in Type 2 Diabetes Mellitus
por: Rauch, Thomas, et al.
Publicado: (2012)

Emerging role of insulin with incretin therapies for management of type 2 diabetes
por: Ahluwalia, Rupa, et al.
Publicado: (2011)

Comparative study on the modulation of incretin and insulin homeostasis by butyrate in chicken and rabbit
por: Mátis, Gábor, et al.
Publicado: (2018)

The Links of Ghrelin to Incretins, Insulin, Glucagon, and Leptin After Bariatric Surgery
por: Skuratovskaia, Daria, et al.
Publicado: (2021)

Incretin and insulin signaling as novel therapeutic targets for Alzheimer’s and Parkinson’s disease
por: Nowell, Joseph, et al.
Publicado: (2022)

Postprandial hyperlipidemia, endothelial dysfunction and cardiovascular risk: focus on incretins
por: Ansar, Sameer, et al.
Publicado: (2011)

The cardiovascular safety of incretin-based therapies: a review of the evidence
por: Petrie, John R
Publicado: (2013)

Cardiovascular effects of the incretin-based therapy: the good, the bad, or the ugly?
por: Cho, Young Min
Publicado: (2015)

Molecular mechanisms of incretin hormone secretion()
por: Ezcurra, Marina, et al.
Publicado: (2013)

Insulin Secretion and Incretin Hormone Concentration in Women with Previous Gestational Diabetes Mellitus
por: Yu, Sung Hoon, et al.
Publicado: (2011)

Combining Incretin-Based Therapies With Insulin: Realizing the potential in type 2 diabetes
por: Vora, Jiten
Publicado: (2013)

β‐Cell glutamate signaling: Its role in incretin‐induced insulin secretion
por: Yokoi, Norihide, et al.
Publicado: (2016)

Gene x Gene Interactions Highlight the Role of Incretin Resistance for Insulin Secretion
por: Jaghutriz, Benjamin Assad, et al.
Publicado: (2019)

Cardiovascular safety trials of incretin‐based drugs: What do they mean?
por: Yabe, Daisuke, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_tohv3jrkq702gu16o5r9cqgc1k